Evidence map›Paper›PMID 41485175›Full record

ArticlePharmacoEconomics2026

Spectrum of Models for Assessing the Cost Effectiveness of Total Knee Replacement Implants: A Comparison of Discrete-Time Cohort Markov and Continuous-Time Individual-Level Multistate Models.

Yixin Xu, Elsa M R Marques, Nicky J Welton, Linda P Hunt, Michael Whitehouse, Ashley W Blom, Andrew D Beswick, Howard H Z Thom

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yixin XuPopulation Health Sciences, Bristol Medical School, University of Bristol, 1-5 Whiteladies Rd, Bristol, BS8 1NU, UK. yx18392@bristol.ac.uk.ORCID http://orcid.org/0000-0003-2201-9717
Elsa M R MarquesTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Nicky J WeltonPopulation Health Sciences, Bristol Medical School, University of Bristol, 1-5 Whiteladies Rd, Bristol, BS8 1NU, UK.
Linda P HuntTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Michael WhitehouseTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Ashley W BlomFaculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Andrew D BeswickTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Howard H Z ThomPopulation Health Sciences, Bristol Medical School, University of Bristol, 1-5 Whiteladies Rd, Bristol, BS8 1NU, UK.

Funding

Research for Patient Benefit Programme PB-PG-1013-32010
6 · The paper itself

Abstract

BACKGROUND AND

objectiveA primary elective total knee replacement is routinely used for patients with advanced osteoarthritis. Knee implants differ in characteristics (constraint, fixation, mobility), costs, need for revisions and other health outcomes, and so models evaluating their relative cost effectiveness are required to optimise decision making. Economic modelling approaches differ in complexity, the simplest in use being discrete time Markov models (DTMMs). Continuous-time Markov models (CTMMs) can capture transition timing in finer detail, and can more flexibly relax the constant hazard assumption. Multistate microsimulation can more easily capture patient history and time dependence. This paper aims to explore how the choice of modelling approach influences the cost effectiveness of various implant types for a total knee replacement. Based on the frequency of implant use in the National Joint Registry, 12 commonly used implants were included in the analysis.

methodsWe compared four different models of increasing complexity for male and female individuals in five age categories undergoing a total knee replacement. The DTMM and constant hazard CTMM assumed fixed revision probabilities over time. The individual-level CTMM with splines were semi-Markov, allowing time-varying rates of first revision surgery. The multistate microsimulation incorporated time-dependent splines for all revision rates but also dependence on time spent in previous health states. All revision rates were estimated using data from the National Joint Registry. The models were implemented using the hesim package in R.

resultsUnder the constant hazard assumption, DTMM and CTMM yielded similar results, identifying the most commonly used implant as the most cost effective. However, using the spline-based hazard CTMM and patient history informed multistate microsimulation, other implants were identified as the most cost-effective options. The increased model complexity required high-performance computing facilities for CTMMs and multistate microsimulation.

conclusionsThis study shows that the choice of model can impact cost-effectiveness results. The multistate microsimulation model, which incorporates time-dependent transitions, provides a realistic representation of patient pathways over time, but is computationally complex and may be preferable only when time-varying risks are a key factor. The CTMM or DTMM models may be more efficient when data are limited or computational resources are constrained. Improving the accuracy and applicability of economic models can improve healthcare decision making. Future research should extend these methodologies to other disease areas, refine continuous-time models and explore their impact across diverse healthcare contexts.

Indexed as

Arthroplasty, Replacement, KneeKnee ProsthesisModels, EconomicOsteoarthritis, KneeAgedAged, 80 and overCohort StudiesCost-Benefit AnalysisCost-Effectiveness AnalysisFemaleHumansMaleMarkov ChainsMiddle AgedRegistriesReoperation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.